These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6695525

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Prognostic importance of determining steroid hormone receptors in breast tumors].
    Bassalyk LS, Murav'eva NI, Smirnova KD, Kuz'mina ZV, Gershteĭn ES.
    Vopr Onkol; 1982; 28(5):82-8. PubMed ID: 7090287
    [Abstract] [Full Text] [Related]

  • 5. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
    Bassalyk LS, Kuz'mina ZV, Murav'eva NI, Smirnova KD, Vishniakova VV.
    Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
    [Abstract] [Full Text] [Related]

  • 6. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
    Makhova EE, Gershteĭn ES, Smirnova KD, Murav'eva NI, Kuz'mina ZV.
    Vopr Onkol; 1984; 30(12):36-40. PubMed ID: 6516272
    [Abstract] [Full Text] [Related]

  • 7. The use of steroïd hormone receptors in the treatment of human breast cancer: a review.
    Osborne CK, McGuire WL.
    Bull Cancer; 1979; 66(3):203-9. PubMed ID: 385079
    [Abstract] [Full Text] [Related]

  • 8. [Prognostic value of the level of steroid hormone receptors in cancer of the large intestine].
    Bassalyk LS, Korotkova TV, Prorokov VV, Murav'eva NI, Smirnova KD.
    Vopr Onkol; 1987; 33(9):43-6. PubMed ID: 3660756
    [Abstract] [Full Text] [Related]

  • 9. Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens.
    Teicher I, Tinker MA, Auguste LJ, Laufer H, Stein TA, Wise L.
    Surgery; 1985 Oct; 98(4):784-91. PubMed ID: 4049250
    [Abstract] [Full Text] [Related]

  • 10. Steroid receptor analyses of nine human breast cancer cell lines.
    Horwitz KB, Zava DT, Thilagar AK, Jensen EM, McGuire WL.
    Cancer Res; 1978 Aug; 38(8):2434-7. PubMed ID: 667841
    [Abstract] [Full Text] [Related]

  • 11. [Degree of manifestation of therapeutic pathomorphosis and the nature of the change in the estrogen and progesterone receptors after the radiation and chemotherapy of breast cancer].
    Ermilova VD, Koposova TL, Murav'ëva NI, Kuz'mina ZV.
    Vopr Onkol; 1985 Aug; 31(12):69-73. PubMed ID: 4082510
    [Abstract] [Full Text] [Related]

  • 12. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP, Hoop JG, van Beers M, van Rodijnen N, Pannebakker M, Nap M.
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [Abstract] [Full Text] [Related]

  • 13. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurküla M, Langman G, Mazzucchelli L, Braye S, Grigolato P, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Goldhirsch A, Gusterson B, International Breast Cancer Study Group.
    J Natl Cancer Inst; 2006 Nov 01; 98(21):1571-81. PubMed ID: 17077359
    [Abstract] [Full Text] [Related]

  • 14. Blood hemoglobin level and treatment outcome of early breast cancer.
    Henke M, Sindlinger F, Ikenberg H, Gerds T, Schumacher M.
    Strahlenther Onkol; 2004 Jan 01; 180(1):45-51. PubMed ID: 14704844
    [Abstract] [Full Text] [Related]

  • 15. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E, Haffty BG.
    Cancer J Sci Am; 2000 Jan 01; 6(1):28-33. PubMed ID: 10696736
    [Abstract] [Full Text] [Related]

  • 16. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
    Voogd AC, Crommelin MA, Repelaer van Driel OJ, Tutein Nolthenius-Puylaert MC, Vreugdenhil G, Coebergh JW.
    Ned Tijdschr Geneeskd; 1998 Aug 01; 142(31):1772-8. PubMed ID: 9856143
    [Abstract] [Full Text] [Related]

  • 17. [Steroid hormone receptors in malignant tumors of the large intestine].
    Korotkova TV, Bassalyk LS, Knysh VI, Prorokov VV.
    Vopr Onkol; 1984 Aug 01; 30(9):64-8. PubMed ID: 6495697
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
    Colleoni M, Viale G, Zahrieh D, Pruneri G, Gentilini O, Veronesi P, Gelber RD, Curigliano G, Torrisi R, Luini A, Intra M, Galimberti V, Renne G, Nolè F, Peruzzotti G, Goldhirsch A.
    Clin Cancer Res; 2004 Oct 01; 10(19):6622-8. PubMed ID: 15475452
    [Abstract] [Full Text] [Related]

  • 19. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA, Diamandis EP, Yu H, Look MP, Meijer-van Gelder ME, van Putten WL, Klijn JG.
    Br J Cancer; 1999 Feb 01; 79(5-6):888-94. PubMed ID: 10070886
    [Abstract] [Full Text] [Related]

  • 20. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G, Regan MM, Maiorano E, Mastropasqua MG, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Braye S, Grigolato P, Rusca T, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS.
    J Clin Oncol; 2008 Mar 20; 26(9):1404-10. PubMed ID: 18349391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.